Dosing frequency and adherence in chronic psychiatric disease: systematic review and meta-analysis
2013
Disclosure
Funding and support was provided by AstraZeneca to MAPI Consultancy for the independent systemic review and meta-analysis of the dosing frequency and adherence in chronic psychiatric disease. Medical writing, editorial, and technical support services were provided by Goran Medic of MAPI Consultancy. Goran Medic did not receive any other form of compensation from Astra Zeneca and is fully employed by MAPI Consultancy. TD and OG are former employees of AstraZeneca. The authors report no conflicts of interest in this work.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
36
References
38
Citations
NaN
KQI